A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne
A Multi-Center, Evaluator Blinded, Randomized Clinical Study to Evaluate the Efficacy and Tolerance of Two Acne Treatment Regimens on Subjects With Mild to Moderate Acne Vulgaris
Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
A NA clinical study on Acne Vulgaris, this trial is completed. The trial is conducted by Johnson & Johnson Consumer Inc. (J&JCI) and has accumulated 10 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Mar 2019 — Feb 2020 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Dec 2018 — Mar 2019 [monthly]
Completed NA
Status: Withheld → Completed · Phase: None → NA
-
Sep 2018 — Dec 2018 [monthly]
Withheld
-
Jun 2018 — Sep 2018 [monthly]
Withheld
-
Apr 2018 — Jun 2018 [monthly]
Withheld
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Withheld NA
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johnson & Johnson Consumer Inc. (J&JCI)
For direct contact, visit the study record on ClinicalTrials.gov .